A small fragment of a natural hormone
KPV is made of just three amino acids: lysine, proline and valine. It's the tail end of alpha-melanocyte-stimulating hormone (alpha-MSH), which your body produces and which has known anti-inflammatory activity.
Researchers have studied KPV to see whether this small fragment can reduce inflammation without the wider hormonal effects of alpha-MSH.
What the gut research found
The best-known study was published in Gastroenterology in 2008. It tested KPV in human intestinal cells and immune cells in the laboratory, and in two mouse models of colitis.
- KPV entered cells through PepT1, a transporter that becomes more active in the inflamed colon.
- In cells, very low concentrations reduced inflammatory signalling and the release of pro-inflammatory cytokines.
- In mice, KPV added to drinking water reduced colitis and lowered markers of inflammation.
The authors suggested KPV might become a new treatment for inflammatory bowel disease. That remains a research hypothesis, because this study didn't test KPV in people.
How it may work
An earlier mouse study found that KPV reduced the build-up of inflammatory white blood cells. Its effect didn't appear to depend on the melanocortin receptors used by alpha-MSH, and the authors thought it more likely acted by inhibiting IL-1 beta, an inflammatory signal.
This distinction matters because the mechanism still isn't settled. Taken together, these studies show how KPV behaves in early research, not how well it treats a person's condition.
What about skin?
Interest in KPV for skin comes from the wider anti-inflammatory research on alpha-MSH and related fragments. We didn't find good-quality human trials showing that injected KPV improves inflammatory skin conditions, so any benefit is unproven.
What we don't know yet
- Whether KPV works in people with inflammatory bowel disease or skin conditions
- Whether an injection works as well as the oral route tested in mice
- The best dose and treatment length
- Long-term safety in humans
KPV doesn't replace your current treatment
Conditions such as Crohn's disease and ulcerative colitis need proper specialist care. Don't stop or reduce a prescribed medicine because you've started KPV. Blood in your stool, weight loss, fever or severe abdominal pain should be assessed by a doctor promptly.
Who should avoid it
Ambrosia's product information lists these reasons not to use KPV:
- Active cancer
- Pregnancy or breastfeeding
- Known hypersensitivity to melanocortin fragments
Tell your doctor if you use immunosuppressants, biologics or other anti-inflammatory medicines. Possible side effects include injection-site redness or soreness, mild nausea and headache.
How it's prescribed
Ambrosia dispenses KPV as a 14 mg cartridge in 2,4 ml, usually injected once a day. Your doctor decides whether it suits you and sets your dose. Every Ambrosia treatment requires a prescription.
This article is for educational purposes only and is not medical advice.


